Literature DB >> 34926048

The Spectrum of Clinical Presentation of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Young Patients of Our Community.

Hikmatullah K Sherani1, Mohammad Hasan2,3, Hassan Mumtaz4,5,6,7.   

Abstract

Background Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory, demyelinating syndrome of the central nervous system (CNS) which affects the spinal cord and optic nerves. The aim of our study was to evaluate the clinical appearance of multiple sclerosis and neuromyelitis optica spectrum disease in young children in our community Materials and methods This cross-sectional study was done in the neurology departments of the Combined Military Hospital & Pak Emirates Military Hospital Rawalpindi for six months from April 2020 to September 2020. Eighty people between the ages of 18 and 45 with Guillain-Barre syndrome (GBS), multiple sclerosis (MS), and neuromyelitis optica spectrum disorder participated in this prospective research. The patient's demographic profile includes information such as age, gender, length and kind of sickness, and symptoms. The relationship of socio-demographic factors was assessed with the involvement of more than one organ system at the time of presentation. Results The final study comprised of 80 patients of whom 31 (38.5 percent) were men and 49 (61.25%) were women. Fifty-four (67.5%) patients were diagnosed with multiple sclerosis while 26 (32.5%) had neuromyelitis optica spectrum disorders. Most of the patients presented with sensory symptoms followed by visual disturbances. Twenty-nine (37%) had involvement of more than one system while 51 (63%) had involvement of only one system at the time of presentation. Female gender and having a diagnosis of multiple sclerosis had a statistically significant relationship with involvement of one than one system. Conclusions In individuals with MS and NMO, motor, sensory, and visual symptoms were often observed at the time of presentation. Involvement of one than one system at the time of presentation was fairly common among these patients and females and patients having a diagnosis of multiple sclerosis were more at risk of involvement of more than one system.
Copyright © 2021, Sherani et al.

Entities:  

Keywords:  aquaporin-4; clinical profile; multiple sclerosis; neuromyelitis optica; optic neuropathy; opticospinal; rion; transverse myelitis

Year:  2021        PMID: 34926048      PMCID: PMC8671079          DOI: 10.7759/cureus.19576

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  15 in total

1.  Tumefactive multiple sclerosis (TMS): A case series of this challenging variant of MS.

Authors:  Joseph V Villarreal; Maria J Abraham; Joanne Allieza G Acevedo; Prashant K Rai; Neeharika Thottempudi; Xiang Fang; Bhanu Gogia
Journal:  Mult Scler Relat Disord       Date:  2020-12-26       Impact factor: 4.339

2.  Sequential Optic Neuritis: A Neuromyelitis Optica Spectrum Disorder.

Authors:  Mehtab Alam; Mian Ayaz Ul Haq; Asif Iqbal; Kaleem Ullah; Danish Nabi
Journal:  J Coll Physicians Surg Pak       Date:  2019-04       Impact factor: 0.711

Review 3.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

4.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

5.  A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.

Authors:  Kavita Sohan Barhate; Malti Ganeshan; Bhim Sen Singhal
Journal:  Ann Indian Acad Neurol       Date:  2014-01       Impact factor: 1.383

6.  Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia.

Authors:  Saima Nazish; Rizwana Shahid; Azra Zafar; Foziah Alshamrani; Abdullah Al Sulaiman; Majed Alabdali; Danah Aljaafari; Esraa Al Wabari; Fahd A Alkhamis
Journal:  J Clin Neurol       Date:  2018-07       Impact factor: 3.077

7.  Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2019-01-21       Impact factor: 44.182

8.  A Systematic Assessment of Prevalence, Incidence and Regional Distribution of Multiple Sclerosis in Bavaria From 2006 to 2015.

Authors:  Tanja Daltrozzo; Alexander Hapfelmeier; Ewan Donnachie; Antonius Schneider; Bernhard Hemmer
Journal:  Front Neurol       Date:  2018-10-30       Impact factor: 4.003

9.  Neuromyelitis optica spectrum disorder: Patient experience and quality of life.

Authors:  Janine Beekman; Aysha Keisler; Omar Pedraza; Masayuki Haramura; Athos Gianella-Borradori; Eliezer Katz; John N Ratchford; Gerard Barron; Lawrence J Cook; Jacinta M Behne; Terrence F Blaschke; Terry J Smith; Michael R Yeaman
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-06-20

10.  Multiple sclerosis.

Authors:  Shilpa Klocke; Nicole Hahn
Journal:  Ment Health Clin       Date:  2019-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.